Clinical Management in Alzheimer’s Disease in the Era of Disease-Modifying Therapies

被引：0
|
作者：
Michael H. Guo
Sanjeev N. Vaishnavi
机构：
[1] Penn Memory Center,Department of Neurology, Perelman School of Medicine
[2] University of Pennsylvania,undefined
来源：
Current Treatment Options in Neurology | 2023年 / 25卷
关键词：
Alzheimer’s disease; Dementia; Amyloid; ARIA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：121 / 133
页数：12
相关论文
共 50 条
  • [41] Disease-Modifying Alzheimer's Disease Therapeutic Candidate
    Kelleher-Andersson, Judith
    [J]. NEUROTHERAPEUTICS, 2012, 9 (03) : 679 - 680
  • [42] Disease-modifying treatment approaches for Alzheimer's disease
    Froelich, Lutz
    Hausner, Lucrezia
    [J]. NERVENARZT, 2021, 92 (12): : 1239 - 1248
  • [43] Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease
    Sheila Seleri Assunção
    Reisa A. Sperling
    Craig Ritchie
    Diana R. Kerwin
    Paul S. Aisen
    Claire Lansdall
    Alireza Atri
    Jeffrey Cummings
    [J]. Alzheimer's Research & Therapy, 14
  • [44] Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease
    Assuncao, Sheila Seleri
    Sperling, Reisa A.
    Ritchie, Craig
    Kerwin, Diana R.
    Aisen, Paul S.
    Lansdall, Claire
    Atri, Alireza
    Cummings, Jeffrey
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [45] The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer's disease
    Sarazin, Marie
    Lagarde, Julien
    El Haddad, Ines
    de Souza, Leonardo Cruz
    Bellier, Bertrand
    Potier, Marie-Claude
    Bottlaender, Michel
    Dorothee, Guillaume
    [J]. NATURE AGING, 2024, 4 (06): : 761 - 770
  • [46] New horizons for Alzheimer's disease: Potential disease-modifying anti-amyloid therapies
    Orgogozo, J-M.
    Golde, T. E.
    Wilcock, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 327 - 327
  • [47] Editorial: Targets for Disease-Modifying Therapies in Alzheimer's Disease, Including Amyloid and Tau Protein
    Parums, Dinah V.
    [J]. MEDICAL SCIENCE MONITOR, 2021, 27
  • [48] Disease-Modifying Therapies in Alzheimer’s DiseaseHow Far Have We Come?
    Michael Hüll
    Mathias Berger
    Michael Heneka
    [J]. Drugs, 2006, 66 : 2075 - 2093
  • [49] Cancer research provides a model for advancing clinical trials in dementia in the era of disease-modifying Alzheimer's-type dementia therapies
    Jicha, Gregory A.
    Tucker, Thomas C.
    Arnold, Susanne M.
    Nelson, Peter T.
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [50] Challenges to the development of disease-modifying therapies in Parkinson's disease
    Schapira, A. H. V.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 16 - 21
12345